Catalyst Wire Dossier Catalyst Wire Dossier

Skytrofa

lonapegsomatropin · Ascendis Pharma
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for Skytrofa, covering 2021-08-25 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders [Phase 3]

See pricing